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ORIGINAL AND CLINICAL ARTICLES
Despite recent developments in intensive care, 
sepsis remains one of the leading problems faced by 
clinicians involved in the field. Sepsis is the cause of 
approximately 34.0% and 37.4% admissions to Polish 
and European intensive care units (ICU), respectively, 
and it is associated with very high mortality, reach-
ing 32.2% among patients with severe sepsis [1, 2]. 
Alarmingly, there is an upward trend in its preva-
lence and mortality rate worldwide [3]. Furthermore, 
sepsis is a crucial issue for the policymakers, due to the 
high cost of ICU treatment, estimated to be $27,461 
per case, and the significant re-hospitalisation rate 
among sepsis survivors, reaching 63% [4, 5]. Consid-
ering the aforementioned data, precise and reliable 
predictive factors in sepsis are needed. However, 
the search for further prognostic biomarkers is on-
going.
Sepsis is associated with dysfunction of mul-
tiple organs. Respiratory failure, hypotension, and/
or shock contribute to hypoxia, thus reducing the 
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ability of cells to produce ATP (Figure 1). The im-
pact of severe systemic diseases on thyroid me-
tabolism is increasingly emphasised by researchers. 
The phe nomenon is described as non-thyroidal ill-
ness syndrome. The hypothesis about the origin of 
the syndrome claims that it is a combination of phy-
siological adaptation and pathological response to 
systemic lesions. According to current knowledge, 
the mechanism of developing a non-thyroidal dis-
ease syndrome is associated with a reduced signal-
ling of thyroid-stimulating hormone (TSH) produc-
tion by the hypothalamus. However, the basic reason 
for these changes has not been clearly explained [6].
Based on the available knowledge we hypo-
thesise that thyroid function may be associated with 
outcomes in patients with sepsis and therefore its 
markers could be useful clinical risk predictors. Our 
aim was to evaluate the value of free triiodothyro-
nine (fT3) and free thyroxine (fT4) as predictors of 
survival among patients with sepsis.
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Abstract
Background: Sepsis is a life-threatening organ dysfunction caused by a dysregulated 
host reaction to infection. There is an upward trend in sepsis prevalence and mortality 
worldwide. Sepsis causes hypoxia, which reduces the ability of cells to produce ATP. 
This process is also influenced by thyroid hormones. Some of the previous studies re-
vealed association between the mortality rate in sepsis and thyroid hormone levels. 
We aimed to evaluate thyroid hormones’ predictive value in septic patients.
Methods: Forty-nine adult patients with sepsis admitted to the Intensive Care Unit 
of Allergy and Immunology Department at the University Hospital in Krakow, Poland, 
between 2015 and 2017 were enrolled in the study. Blood samples were obtained 
from septic patients immediately after establishing the diagnosis, in order to measure 
free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) 
levels. The primary endpoint was 30-day survival rate. The secondary endpoint was 
death anytime during intensive care unit (ICU) stay. 
Results: Patients who died within 30 days had significantly lower level of fT4 than survi-
vors (9.8 vs. 12.7 pmol L-1; P = 0.033). There was no statistically significant difference be-
tween the groups in TSH and fT3 levels. As for the secondary endpoint, both fT3 (1.6 vs. 
1.8 pmol L-1; P = 0.021) and fT4 (9.8 vs. 12.7 µIU mL-1; P = 0.019) levels were significantly 
lower among non-survivors compared to survivors, which was not the case for TSH.
Conclusions: Thyroid hormone levels were significantly lower among patients who died 
during ICU stay. The results of the presented study suggest that fT3 and fT4 levels may 
be taken into consideration as potential new prognostic factors in sepsis.
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METHODS
The study was initiated in 2015, when sepsis was 
being diagnosed according to the 2nd Sepsis Consen-
sus, based on systemic inflammatory response syn-
drome (SIRS) criteria, determined by a coincidence 
of two out of the four factors mentioned below:
• heart rate > 90 beats min-1,
• body temperature > 38°C or < 36°C,
• WBC count > 12 G L-1 or < 4 G L-1,
• respiratory rate > 20 breaths/min or PaCO2 < 32 
mm Hg [8].
This prospective study includes patients admit-
ted to the Intensive Care Unit of Allergy and Immu-
nology Department at the University Hospital in Kra-
kow, Poland between 2015 and 2017. The inclusion 
criteria were: age ≥ 18 years and sepsis diagnosed 
according to the 2nd International Definition [8]. 
The exclusion criteria included: pregnancy, history 
of thyroid disease, and lack of patient’s consent. 
Acute Physiology and Chronic Health Evaluation III 
(APACHE III), Acute Physiology and Chronic Health 
Evaluation IV (APACHE IV), Sepsis-related Organ Fail-
ure Assessment (SOFA), Simplified Acute Physiology 
Score (SAPS), and Multiple Organ Dysfunction Score 
(MODS) scales were calculated for each patient. 
Clini cal data were collected during hospitalisation. 
Blood samples for TSH, fT3, and fT4 level measure-
ments were obtained from septic patients immediately 
after establishing the diagnosis. The measurements 
were performed using an ECLIA electro-chemilumi-
nescence immunoassay analyser (Cobas 6000, Roche, 
Switzerland).
The primary endpoint was 30-day mortality rate. 
The secondary endpoint was ICU mortality. The de-
sign of the study is presented in Figure 2.
The results were interpreted statistically using 
U Mann-Whitney test, Student’s t-test, and ROC 
curve analysis by means of Statistica 12 software 
(Statsoft, version 12.5.192.0, Tulsa, USA). Continuous 
variables were compared using U Mann Whitney 
test or Student’s t-test as appropriate and presented 
as median (interquartile range) and mean (standard 
deviation), respectively. Discrete variables were pre-
sented as n (%). P values < 0.05 were considered sta-
tistically significant. 
All procedures performed in the study involving 
human participants were in accordance with the 
ethical standards of the institutional and national 
research committee and with the 1964 Helsinki dec-
laration and its later amendments or comparable 
ethical standards. The study was approved by the 
FIGURE 1. Opposite influence of sepsis and thyroid hormones on intracellular ATP production (based on [7])
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Bioethics Committee of the Jagiellonian University 
(approval number: 122.6120.231.2015).
RESULTS
We enrolled 49 patients with a mean age of 59.4 
(± 14.1) years, diagnosed with sepsis, 31 (63.3%) 
of whom were males. The 30-day and ICU mortal-
ity in the study group amounted to 40.8% (20/49) 
and 42.9% (21/49), respectively. In our study group 
sepsis was caused by bacterial (38.8%, 19/49) and 
viral/fungal (24.5%, 12/49) infection or the patho-
gen remained unknown (36.7%, 18/49). The most 
common sites of infection were the following: re-
spiratory tract (65.3%, 32/49), blood (8.2%, 4/49), 
urinary tract (4.1%, 2/49), and leg ulcer (2%, 1/49). 
In seven cases (14.3%) multiple sites of infection 
were observed. The origin of infection remained 
unknown in three patients. Median predicted mor-
tality rate in the study population based on APACHE 
IV score on the first day of hospitalisation amounted 
TABLE 1. Comparison of demography data, comorbidities and APACHE scores between survivors and non-survivors (during the whole ICU stay)
Factor All , n = 49 ICU stay
Survivors, n = 28 Non-survivors, n = 21 P 
Demography
Age (years) 59.4 ± 14.1 55.3 ± 14.8 64.9 ± 10.9 0.017 
Male 31 (63) 17 (55) 14 (45) 
Female 18 (37) 11 (61) 7 (39) 
Length of the ICU stay (days) 13.5 (9–20)  14 (10–23)  13 (5–20) 0.216 
Comorbidities
Arterial hypertension 16 (33) 12 (43) 4 (19) 
Diabetes mellitus 11 (22) 4 (14) 7 (33) 
Heart failure 6 (12) 4 (14) 2 (10) 
Atrial fibrillation 5 (10) 3 (11) 2 (10) 
Hematological diseases 5 (10) 3 (11) 2 (10) 
Oncological diseases 4 (8) 3 (11) 1 (5) 
APACHE IV 
Value 114.5 (105.3–125.3) 108 (89–113) 125 (117–149) 0.0003 
Predicted mortality rate 79.1% (65.3–87.4) 72.7% (58.1–79.4) 84.2% (79.7–93.1) 0.0008 
Values are presented as n (%) or median (IQR) or mean (SD).
to 79.1%. Detailed demographic, clinical data as well 
as APACHE scores are shown in Table 1. 
Patients who died had significantly lower fT3 
and fT4 levels in comparison with survivors. This was 
not observed in the case of TSH (Table 2, Figure 3). 
All patients who died during the hospitalisation had 
fT3 values below the lower reference range, and we 
did not observe such a relationship regarding fT4 
and TSH. Figure 3 shows the differences in fT3, fT4, 
and TSH depending on survival status in two end-
points.
ROC curves for fT3 and fT4 as predictors of sur-
vival revealed that AUC values were moderately 
high and slightly better for the secondary end-
point – death anytime during ICU stay (fT3 [AUC = 
0.7; P = 0.009]; fT4 [AUC = 0.7; P = 0.014]) than for 
the primary endpoint – 30-day survival rate (fT3 
[AUC = 0.66; P = 0.04]; fT4 [AUC = 0.68; P = 0.028]). 
Figure 4 and 5 present ROC curves for the primary 
and the secondary endpoint, respectively.
TABLE 2. Thyroid hormone levels by mortality rate
 Hormone Range All , n = 49 30th day ICU stay
Survivors 
n = 29
Non-survivors 
n = 20
P Survivors
n = 28 
Non-survivors 
n = 21 
P
fT3 (pmol L-1) 3.1–6.8 1.7 (1.4–2.1) 1.8 (1.5–2.4) 1.6 (1.3–1.9) 0.059 1.8 (1.6–2.4) 1.6 (1.3–1.9) 0.021
fT4 (pmol L-1) 12.0–22.0 11.8 (9.2–15.1) 12.7 (10.6–16.1) 9.8  (8.2–13.6) 0.033 12.7 (10.8–16.1) 9.8 (8.4–13.6) 0.019
TSH (µIU mL-1) 0.3–4.2 0.5 (0.3–1.7) 0.5 (0.3–1.7) 0.4 (0.2–1.7) 0.970 0.5 (0.3–1.5) 0.5 (0.3–2.1) 0.600
Values are presented as median (IQR).
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DISCUSSION
In this prospective study we sought potential 
differences in the thyroid hormone levels mea-
sured immediately after establishing the diagno-
sis of sepsis between survivors and non-survivors. 
The results showed that patients who died within 
30 days of observation had lower levels of fT4. 
Analysis of the secondary endpoint – death anytime 
during ICU stay – indicated lower levels of both fT3 
and fT4 among non-survivors. We did not find any 
signifi cant differences in TSH levels between the 
groups. 
Despite significant progress in sepsis diagnosis 
and management, there is still an upward trend 
in sepsis-associated mortality observed worldwide 
[9–11]. Due to the recent change in sepsis defini-
tion, current epidemiological data remains scarce. 
In the UK between the years 2011 and 2015 sep-
sis and septic shock led to death in 30–33% and 
56–57% cases, respectively [12]. The mortality rate 
we observed in the current study was similar and 
equalled 43%. Its reduction is one of the most im-
portant goals of contemporary intensive care re-
search. Prognostic factors reliably predicting sepsis 
outcome and improvement of the performance of 
commonly used clinical severity scores are needed.
Several publications bring up the topic of the role 
of thyroid hormones in the management of sepsis 
and their impact on the outcomes. In the retrospec-
tive review of 231 patients with surgical sepsis Todd 
et al. [13] showed results similar to those presented 
in the current study, i.e. decreased baseline T3 and 
fT4 levels were associated with mortality. There 
are also other reports that, similarly to ours, docu-
mented a correlation between hypothyroxinaemia 
and mortality in sepsis and/or ICU mortality [14–16]. 
FIGURE 3. The differences in fT3, fT4, and TSH depending on survival status in two endpoints
Free triiodothyronine 
Primary
endpoint
Secondary 
endpoint 
fT
3 
(p
m
ol
 L-
1 )
2.5
2.0
1.5
1.0
0.5
0.0
ns *
Free thyroxine
Primary
endpoint
Secondary 
endpoint 
fT
4 
(p
m
ol
 L-
1 )
2.0
1.5
1.0
0.5
0.0
**
Thyroid-stimulating hormone
Primary
endpoint
Secondary 
endpoint 
TS
H 
(m
lU
 m
L-1
)
2.5
2.0
1.5
1.0
0.5
0.0
ns ns
 Survivors  Non-survivors
1-Sensitivity
Se
ns
iti
vit
y
1.0
0.8
0.6
0.4
0.2
0
fT3 fT4
0                0.2              0.4              0.6              0.8             1.0
FIGURE 5. ROC curves for fT3 and fT4. ICU survival rate. Suggested cut-off points: 
1.8 and 10.5 for fT3 and fT4, respectively
1-Sensitivity
Se
ns
iti
vit
y
2.5
2.0
1.5
1.0
0.5
0.0
fT3 fT4
0                0.2              0.4             0.6              0.8             1.0
FIGURE 4. ROC curves for fT3 and fT4. 30-day survival rate. Suggested cut-off points: 
1.4 and 10.5 for fT3 and fT4, respectively
209
Thyroid hormones in sepsis
Moreover, a study by Meyer et al. [17] suggested a re-
lationship between T3 and fT4 serum level and mor-
tality rate on the last day of hospitalisation; however, 
thyroid hormone levels measured on admission did 
not differ between survivors and non-survivors.
Interestingly, there are also several studies show-
ing an opposite tendency. In the research by Ray 
et al. [18] TSH, T3, and fT4 levels were measured in 180 
critically ill patients after three hours of ICU admission. 
It did not show any statistically significant differences 
in T3 and fT4 levels between patients who had died 
and those who had survived. Nevertheless, numer-
ous factors may explain the contrasting results; for 
instance, the differences in timing of blood sample 
gathering, the fraction of thyroid hormones measured 
(free vs. total), and medical diagnosis. Furthermore, 
the research was performed more than 20 years ago, 
and there was a significant disproportion in the num-
ber of patients between the study groups. 
Available literature suggests that not only thy-
roid hormone baseline levels, but also dynamics 
of their change throughout various stages of the 
disease are related to mortality rate. The explana-
tion of the phenomena requires further prospective 
studies, performed on larger population with serial 
thyroid hormone measurements [18]. This will allow 
the precise evaluation of prognostic values of thy-
roid hormones in sepsis, and could also shed some 
light on the potential therapeutic value of thyroid 
hormone supplementation.
The current study has several limitations. The 
study group is rather small and consists of a specific 
population of patients with non-surgical sepsis. Due 
to the low number of events we were not able to 
perform adjusted analysis for the prognostic value 
of thyroid hormones in our cohort, and the group of 
survivors and non-survivors differed significantly in 
terms of age and APACHE IV severity. Moreover, we 
obtained only one blood sample from each patient at 
the very beginning of the disease course, and there-
fore we were unable to observe changing trends in 
thyroid hormone levels during the treatment. Finally, 
we included patients diagnosed with sepsis accord-
ing to the 2nd definition whereas the 3rd is currently 
the binding one. 
CONCLUSIONS
Current study shows that septic patients who do 
not survive tend to have lower thyroid hormones 
levels. Our results suggest that thyroid hormones 
can potentially be taken into consideration as new 
prognostic factors in sepsis. In the future their re-
placement may play some role in sepsis manage-
ment. However, it would require further prospective 
or randomised controlled studies to understand the 
subject better.
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